General Information of the Molecule (ID: Mol00838)
Name
Beta-lactamase (BLA) ,Escherichia coli
Synonyms
Penicillinase; oxa2
    Click to Show/Hide
Molecule Type
Protein
Gene Name
bla
Gene ID
67369352
Sequence
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
    Click to Show/Hide
Function
This is an oxacillin-hydrolyzing beta-lactamase.
    Click to Show/Hide
Uniprot ID
BLO2_ECOLX
        Click to Show/Hide the Complete Species Lineage
Kingdom: N.A.
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Escherichia
Species: Escherichia coli
Type(s) of Resistant Mechanism of This Molecule
  DISM: Drug Inactivation by Structure Modification
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
Click to Show/Hide the Full List of Drugs
Amoxicillin
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Drug Inactivation by Structure Modification (DISM) Click to Show/Hide
Disease Class: Gram-negative bacterial infection [1], [2]
Resistant Disease Gram-negative bacterial infection [ICD-11: 1B74-1G40]
Resistant Drug Amoxicillin
Molecule Alteration Expression
Up-regulation
Experimental Note Identified from the Human Clinical Data
In Vitro Model Escherichia coli 668369
Acinetobacter johnsonii LIM75 40214
Aeromonas allosaccharophila LIM82 656
Citrobacter freundii LIM86 546
Escherichia coli MFDpir 562
Experiment for
Molecule Alteration
Whole genome sequence assay
Experiment for
Drug Resistance
Agar dilution method assay; broth microdilution method assay
Mechanism Description All known class 3 integrons harbour gene cassettes encoding resistance to Beta-lactams (blaIMP, blaGES, blaBEL, blaOXA-256) and aminoglycosides [aac(6')-Ib].
Ceftazidime
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Drug Inactivation by Structure Modification (DISM) Click to Show/Hide
Disease Class: Gram-negative bacterial infection [1], [2]
Resistant Disease Gram-negative bacterial infection [ICD-11: 1B74-1G40]
Resistant Drug Ceftazidime
Molecule Alteration Expression
Up-regulation
Experimental Note Identified from the Human Clinical Data
In Vitro Model Escherichia coli 668369
Acinetobacter johnsonii LIM75 40214
Aeromonas allosaccharophila LIM82 656
Citrobacter freundii LIM86 546
Escherichia coli MFDpir 562
Experiment for
Molecule Alteration
Whole genome sequence assay
Experiment for
Drug Resistance
Agar dilution method assay; broth microdilution method assay
Mechanism Description All known class 3 integrons harbour gene cassettes encoding resistance to Beta-lactams (blaIMP, blaGES, blaBEL, blaOXA-256) and aminoglycosides [aac(6')-Ib].
References
Ref 1 Characterisation of class 3 integrons with oxacillinase gene cassettes in hospital sewage and sludge samples from France and Luxembourg. Int J Antimicrob Agents. 2016 Oct;48(4):431-4. doi: 10.1016/j.ijantimicag.2016.06.018. Epub 2016 Jul 28.
Ref 2 Improved purification and characterization of the OXA-2 beta-lactamase. Biochem J. 1984 Dec 15;224(3):1009-13. doi: 10.1042/bj2241009.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.